Table 2.

Baseline characteristics of T2D subjects

	T2D Con (n = 29)	DN (n = 24)	P	DR (n = 34)	P	DPN (n = 50)	P
Cu (mg/L)	1 (0.94–1.15)	1.26 (1.07–1.42)	0.015*	1.05 (0.92–1.48)	0.717	1.08 (0.92–1.38)	0.298
UCu (μg/L)	29 (24.5–36.5)	37 (28.3–49)	0.947	28.5 (26.8–36)	0.274	32 (22.8–43)	0.815
Zn (mg/L)	0.73 (0.55–0.79)	0.59 (0.48–0.76)	0.157	0.58 (0.46–0.63)	0.002*	0.63 (0.59–0.75)	0.08
UZn (mg/L)	0.47 (0.28–0.53)	0.44 (0.3–0.52)	0.685	0.45 (0.25–0.52)	0.824	0.52 (0.44–0.63)	< 0.001*
Zn/Cu	0.66 (0.55–0.76)	0.5 (0.36–0.56)	0.006*	0.48 (0.4–0.64)	0.012*	0.58 (0.46–0.68)	0.111
Mg (mg/L)	18.6 (15.9–24.5)	16.4 (12.6–25.7)	0.052	23.8 (21.6–28.7)	0.002*	21.6 (15.8–28.6)	0.447
UMg (mg/L)	47.7 (39.4–67.1)	48.2 (39.1–87.7)	0.711	46.4 (37.3–74.1)	0.699	53.5 (42.8–77.5)	0.229
Ca (mg/L)	98.5 (78.9–114.2)	66.8 (55.7–127.7)	0.043*	105.7 (70.9–138.9)	0.832	93.8 (56.7–136.6)	0.853
UCa (mg/L)	84.1 (59.5–138.8)	51.8 (12.7–160.3)	0.646	66.5 (35.9–116.2)	0.256	92.7 (63.7–127)	0.827
Se (mg/L)	0.064(0.048–0.084)	0.061(0.042–0.094)	0.775	0.062(0.038–0.069)	0.243	0.064 (0.046–0.09)	0.776
Use (mg/L)	0.016(0.012–0.03)	0.01(0.01–0.02)	0.033*	0.009(0.007–0.011)	< 0.001*	0.012(0.008–0.02)	0.038*

Data presentation and abbreviations’ spelling are the same as the description for Table 1

^*P < 0.05 vs T2D control group